Trial Profile
A multicentre, randomized, double-blind, parallel-group, controlled study, to assess the efficacy and safety of P-3074 cutaneous spray, solution, in the treatment of male pattern baldness
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Feb 2022
Price :
$35
*
At a glance
- Drugs Finasteride (Primary) ; Finasteride (Primary)
- Indications Alopecia
- Focus Registrational; Therapeutic Use
- Sponsors Polichem
- 01 Feb 2022 Results assessing efficacy and safety of topical finasteride compared with placebo published in the Journal of the European Academy of Dermatology and Venereology
- 06 Mar 2018 Status changed from active, no longer recruiting to completed.
- 22 Sep 2017 Planned End Date changed from 1 Feb 2018 to 1 May 2018.